Search results for "Absolute risk reduction"

showing 2 items of 72 documents

Home treatment of fragile patients with acute pulmonary embolism: a subgroup analysis of the multinational home treatment of pulmonary embolism (HoT-…

2020

Abstract Background and aims Subgroup analyses of randomized trials and cohort studies on direct oral anticoagulants (DOACs) suggested that single direct drug treatment may be effective and safe in elderly and “fragile” patients with acute pulmonary embolism (PE). In a post-hoc analysis of HoT-PE, a prospective multicenter management trial, we studied whether early discharge and home treatment of acute PE is effective and safe in these patients. Methods HoT-PE enrolled patients with acute PE classified as being at low risk based on the modified Hestia criteria and the absence of right ventricular dysfunction. The primary efficacy outcome was symptomatic recurrent VTE, or PE-related death wi…

medicine.medical_specialtybusiness.industryAbsolute risk reductionRenal functionSubgroup analysismedicine.diseasePulmonary embolismPharmacotherapyInternal medicineCardiologyMedicineHome treatmentCardiology and Cardiovascular MedicinebusinessVenous thromboembolismEuropean Heart Journal
researchProduct

Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-ana…

2020

Summary Background The timing of renal replacement therapy (RRT) for severe acute kidney injury is highly debated when no life-threatening complications are present. We assessed whether a strategy of delayed versus early RRT initiation affects 28-day survival in critically ill adults with severe acute kidney injury. Methods In this systematic review and individual patient data meta-analysis, we searched MEDLINE (via PubMed), Embase, and the Cochrane Central Register of Controlled Trials for randomised trials published from April 1, 2008, to Dec 20, 2019, that compared delayed and early RRT initiation strategies in patients with severe acute kidney injury. Trials were eligible for inclusion …

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentAbsolute risk reductionAcute kidney injuryGeneral Medicine030204 cardiovascular system & hematologyurologic and male genital diseasesmedicine.diseaseClinical trial03 medical and health sciences0302 clinical medicineInternal medicineRelative riskMeta-analysisSeverity of illnessmedicine030212 general & internal medicineRenal replacement therapybusinessKidney diseaseThe Lancet
researchProduct